Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsHealth & wellnessBy the numbers: Understanding the toll of inflammatory bowel disease
      Person with hand on stomach

      By the numbers: Understanding the toll of inflammatory bowel disease

      For Colitis and Crohn’s Disease Awareness Week, learn about the challenges of this painful condition—and why Johnson & Johnson continues to seek new treatment options.

      Share Article
      share to

      Living with Crohn’s disease or ulcerative colitis—collectively known as inflammatory bowel disease (IBD)—isn’t easy. Characterized by chronic inflammation of the digestive tract, IBD is an immune-mediated condition that typically causes diarrhea, weight loss, fatigue and abdominal pain.

      But the burden of living with IBD goes beyond the physical pain. People with IBD often talk about the shame and embarrassment of having a “bathroom” disease. No surprise, this can lead to mental health problems such as depression and anxiety.

      Treatment for people with IBD has improved dramatically in the past 25 years since biologic drugs entered the picture. But a significant portion of patients don’t respond to these medications or find that they eventually stop working. That’s why Johnson & Johnson is committed to developing new remedies, in addition to precision medicine approaches that will help speed up diagnosis and help healthcare providers match patients to the best treatment.

      For Colitis and Crohn’s Disease Awareness Week, we’re taking a look at the impact of this painful condition across the globe—and some of the reasons why hope is on the horizon.

      Understanding the toll of inflammatory bowel disease infographic

      Have an idea to transform care for BIPOC communities living with IBD?

      The Johnson & Johnson Innovation Inflammatory Bowel Disease QuickFire Challenge: Innovating for Health Equity is accepting applications.

      More from Johnson & Johnson

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      How robots are helping personalize knee replacement surgery

      For Arthritis Awareness Month, learn the latest about this common procedure and how Johnson & Johnson MedTech is innovating to improve patient outcomes.

      “I couldn’t speak, walk or sit.” Inside a rare autoimmune disease that attacks the muscles

      Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. For Myositis Awareness Month, she shares her story.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.